Literature DB >> 8389761

Mutational analysis of the intracellular domain of the human growth hormone receptor.

P Colosi1, K Wong, S R Leong, W I Wood.   

Abstract

The human growth hormone (GH) receptor contains an extracellular hormone-binding domain of about 246 amino acids, a single transmembrane domain, and a cytoplasmic region of 350 residues. X-ray crystallographic and functional data show that a single GH molecule dimerizes two receptors to initiate receptor signaling. We have constructed a series of truncations of the cytoplasmic domain of the human GH receptor and have examined the function of these truncated receptors by expressing them in the interleukin-3-dependent promyeloid cell line, FDC-P1. When transfected with a functional GH receptor, these cells grow in the presence of GH without interleukin-3. We find that truncated GH receptors containing as few as 54 amino acids of the cytoplasmic domain are able to transmit a GH proliferative signal; thus, at least 84% of the intracellular domain is unnecessary for signaling in this system. The 54-amino-acid region contains a proline-rich sequence that is found in a similar location in most other members of the GH/cytokine receptor family. Perhaps, this sequence is directly involved in the signaling process mediated by this receptor family.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389761

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Modulation of growth factor receptor function by isoform heterodimerization.

Authors:  W P Chang; C V Clevenger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Structural domains of interleukin-2 receptor beta critical for signal transduction: kinase association and nuclear complex-formation.

Authors:  O M Howard; R A Kirken; G G Garcia; R H Hackett; W L Farrar
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

3.  Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.

Authors:  O Colamonici; H Yan; P Domanski; R Handa; D Smalley; J Mullersman; M Witte; K Krishnan; J Krolewski
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

4.  Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.

Authors:  Feida Li; Yong Li; Huan Liu; Xingju Zhang; Chuxin Liu; Kai Tian; Lars Bolund; Hongwei Dou; Wenxian Yang; Huanming Yang; Nicklas Heine Staunstrup; Yutao Du
Journal:  Transgenic Res       Date:  2015-10-28       Impact factor: 2.788

5.  Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.

Authors:  W P Chang; Y Ye; C V Clevenger
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

Review 6.  The prolactin/growth hormone receptor family: structure/function relationships.

Authors:  V Goffin; P A Kelly
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

7.  Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity.

Authors:  L Bénit; G Courtois; M Charon; P Varlet; I Dusanter-Fourt; S Gisselbrecht
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Growth hormone receptor C-terminal domains required for growth hormone-induced intracellular free Ca2+ oscillations and gene transcription.

Authors:  N Billestrup; P Bouchelouche; G Allevato; M Ilondo; J H Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 9.  IL-6 cytokine family and signal transduction: a model of the cytokine system.

Authors:  M Hibi; K Nakajima; T Hirano
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

10.  Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo.

Authors:  M A Goldsmith; A Mikami; Y You; K D Liu; L Thomas; P Pharr; G D Longmore
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.